Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS: ENZN · Delayed Price · USD
+0.015 (11.54%)
May 24, 2024, 9:30 AM EDT - Market closed

Enzon Pharmaceuticals Statistics

Total Valuation

ENZN has a market cap or net worth of $10.76 million. The enterprise value is -$35.23 million.

Market Cap 10.76M
Enterprise Value -35.23M

Important Dates

The last earnings date was Monday, March 18, 2013, before market open.

Earnings Date Mar 18, 2013
Ex-Dividend Date n/a

Share Statistics

ENZN has 74.21 million shares outstanding.

Shares Outstanding 74.21M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 10.84%
Owned by Institutions (%) 48.58%
Float 30.11M

Valuation Ratios

The trailing PE ratio is 48.33.

PE Ratio 48.33
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.23
P/FCF Ratio 7.76
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 89.19, with zero debt.

Current Ratio 89.19
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 3.23% and return on invested capital (ROIC) is -2.55%.

Return on Equity (ROE) 3.23%
Return on Assets (ROA) 3.19%
Return on Capital (ROIC) -2.55%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a


Income Tax -120,000
Effective Tax Rate -8.72%

Stock Price Statistics

The stock price has decreased by -10.27% in the last 52 weeks. The beta is 0.36, so ENZN's price volatility has been lower than the market average.

Beta (1Y) 0.36
52-Week Price Change -10.27%
50-Day Moving Average 0.08
200-Day Moving Average 0.11
Relative Strength Index (RSI) 80.98
Average Volume (30 Days) 25,852

Short Selling Information

The latest short interest is 259,381, so 0.35% of the outstanding shares have been sold short.

Short Interest 259,381
Short Previous Month 298,381
Short % of Shares Out 0.35%
Short % of Float 0.86%
Short Ratio (days to cover) 1.71

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.09M
Pretax Income 1.38M
Net Income 1.50M
EBIT n/a
Earnings Per Share (EPS) $0.00
Full Income Statement

Balance Sheet

The company has $45.99 million in cash and no debt, giving a net cash position of $45.99 million or $0.62 per share.

Cash & Cash Equivalents 45.99M
Total Debt n/a
Net Cash 45.99M
Net Cash Per Share $0.62
Equity / Book Value 46.31M
Book Value Per Share 0.62
Working Capital 45.95M
Full Balance Sheet

Cash Flow

Operating Cash Flow 1.39M
Capital Expenditures n/a
Free Cash Flow 1.39M
FCF Per Share $0.02
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ENZN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 13.90%
FCF Yield 12.88%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date Sep 29, 2017
Split Type n/a
Split Ratio 1:1


Altman Z-Score n/a
Piotroski F-Score 3